#precision-medicine

A Stanford-led study suggests roughly 10% of people carry variants linked to weaker blood-sugar responses to GLP-1 drugs used in Type 2 diabetes.

A machine-learning study from VIB and KU Leuven argues that Parkinson’s is not one disease but a family of molecularly distinct disorders, a finding that could reshape how therapies are developed and matched to patients.

Researchers at City of Hope and TGen report a significant correlation between a tumor’s splicing burden and clinical response to treatment in metastatic renal cell carcinoma.

A Nature Medicine feature describes how a trial built around one baby is becoming a practical example of patient-driven research moving from exception to model.

A study announced by the 23andMe Research Institute identified genetic predictors tied to both GLP-1 weight-loss efficacy and side effects, highlighting a possible path toward more personalized obesity treatment.

A new genome study focused on urban Peruvians points to a larger problem in global health research: Latin American populations remain sparsely represented in genetic epidemiology.

Optical genome mapping detects previously missed genetic variants in nearly 20% of acute leukemia patients, potentially changing treatment plans.

Indiana University researchers discovered that age-related blood mutations may drive severe inflammatory bowel disease, identifying a potential new drug target for Crohn's and colitis.

A multi-omics approach achieves 92% accuracy in forecasting organ failure and mortality in trauma patients, days before symptoms appear.

Researchers identify blood-based biomarkers that forecast trauma patient outcomes days before clinical signs appear, transforming critical care.